Published online before print April 3, 2003, doi: 10.1161/01.STR.0000068171.01248.97
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:1276.)
© 2003 American Heart Association, Inc.
Original Contributions |
ATP-Sensitive Potassium Channels Mediate Dilatation of Basilar Artery in Response to Intracellular Acidification In Vivo
From the Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Correspondence to Takanari Kitazono, MD, PhD, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. E-mail kitazono{at}intmed2.med.kyushu-u.ac.jp
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Background and Purpose— During cerebral ischemia, both hypoxia and hypercapnia appear to produce marked dilatation of the cerebral arteries. Hypercapnia and hypoxia may be accompanied by extracellular and intracellular acidosis, which is another potent dilator of cerebral arteries. However, the precise mechanism by which acidosis produces dilatation of the cerebral arteries is not fully understood. The objective of the present study was to examine the mechanisms by which intracellular acidosis produces dilatation of the basilar artery in vivo.
Methods— Using a cranial window in anesthetized rats, we examined responses of the basilar artery to sodium propionate, which was used to cause intracellular acidosis specifically. Expression of subunits of potassium channels was determined by reverse transcription and polymerase chain reaction (RT-PCR).
Results— Topical application of propionate increased diameter of the basilar artery in a concentration-related manner. Propionate-induced dilatation of the artery was attenuated by glibenclamide, an inhibitor of ATP-sensitive potassium channels. However, inhibitors of nitric oxide synthase (NG-nitro-L-arginine), large-conductance calcium-activated potassium channels (iberiotoxin), and cyclooxygenase (indomethacin) did not affect the vasodilatation. Expression of mRNA for SUR2B and Kir6.1 was detected, with the use of RT-PCR, in the cultured basilar arterial muscle cells.
Conclusions— The findings suggest that intracellular acidification may produce dilatation of the basilar artery through activation of ATP-sensitive potassium channels in vivo. Kir6.1/SUR2B may be the major potassium channels that mediate propionate-induced dilatation of the artery.
Key Words: muscle, smooth • propionic acids • vasodilation
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
During cerebral ischemia, both hypoxia and hypercapnia appear to produce marked dilatation of the cerebral arteries.1 The vasodilator responses may increase cerebral perfusion for maintenance of oxygen delivery to brain tissue. Both hypoxia and hypercapnia may be accompanied by extracellular and/or intracellular acidosis. Recent evidence has suggested that acidosis itself produces marked relaxation of the cerebral arteries in vitro.2,3 Thus, extracellular and intracellular acidosis may play a major role in dilatation of the cerebral arteries during hypoxia and hypercapnia.4
Hypoxic dilatation of the cerebral arteries appears to be mediated by activation of ATP-sensitive potassium (KATP) channels.5,6 On the other hand, vasodilatation induced by hypercapnia is reported to be mediated mainly by nitric oxide (NO).7,8 Thus, the mechanisms by which acidosis produces dilatation of the cerebral arteries may be quite different between hypoxia and hypercapnia. It is reported that extracellular pH (pHo) rather than intracellular pH (pHi) may be the major determinant of hypercapnia-induced, NO-dependent relaxation of the cerebral arteries in vitro.3 Hypoxia appears to produce dilatation of the cerebral arterioles through activation of KATP channels that is independent of pHo changes,4 suggesting that pHo may not be important in hypoxia-induced activation of KATP channels in cerebrovascular muscle.
Recently, Xu et al9 showed that KATP channels expressed in Xenopus oocytes are activated directly by intracellular but not extracellular acidosis. The findings suggest that KATP channels contain their pH-sensitive sites in the inside of the cell membrane. However, it is not known whether selective intracellular acidosis activates KATP channels and thereby produces dilatation of the cerebral arteries in vivo. Thus, the first objective of the present study was to test the hypothesis that intracellular acidosis of the basilar arterial muscle cells produces dilatation of the artery through activation of KATP channels in vivo.
The activity of KATP channels has been shown in cerebrovascular muscle and appears to play an important role in dilator responses of the cerebral arteries.5,6,10,11 It has been shown that KATP channels are hetero-octamers consisting of 4 sulfonylurea receptors (SUR) interacting with 4 channel subunits (Kir channels).12,13 SUR2B may be the major SUR in the smooth muscle cells of systemic arteries.14 Both Kir6.1 and Kir6.2 are reported to be present in vascular muscle cells.9,15,16 However, it is not known which Kir is expressed in the cerebral arterial muscle. Thus, the second objective was to determine SUR and Kir subunits expressed in the basilar arterial muscle cells.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
This experiment was reviewed by the Committee on the Ethics of Animal Experiments in the Faculty of Medicine, Kyushu University, and performed under the control of the Guidelines for Animal Experiments in the Faculty of Medicine, Kyushu University, and the Law (No. 105) and Notification (No. 6) of the Japanese government.
Cranial Window
Experiments were performed on male Sprague-Dawley rats (weight, 400±8 g; age, 3.4±0.2 months [mean±SEM]) anesthetized with amobarbital (100 mg/kg IP). Anesthesia was supplemented intravenously at 20 to 25 mg/kg per hour. The trachea was cannulated, and the animals were mechanically ventilated with room air and supplemental oxygen. Skeletal muscle paralysis was produced with d-tubocurarine chloride (2 mg/kg). Depth of anesthesia was evaluated by applying pressure to a paw or the tail and observing changes in heart rate or blood pressure. When such changes occurred, additional anesthetic was administered. Catheters were placed in both femoral arteries to measure systemic arterial pressure and to obtain arterial blood samples. A femoral vein was cannulated for infusion of drugs.
A craniotomy was prepared over the ventral brain stem as previously described in detail.17 After a part of the dura was opened, the cranial window was suffused with artificial cerebrospinal fluid (CSF) (temperature=37°C; ionic composition [in mmol/L]: 132 NaCl, 2.95 KCl, 1.71 CaCl2, 0.65 MgCl2, 24.6 NaHCO3, 3.69 D-glucose) that was bubbled continuously with appropriate gases. The diameter of the blood vessel was measured with the use of a microscope equipped with a television camera coupled to an auto-width analyzer (C3161, Hamamatsu Photonics KK). After craniotomy was performed, pH, PCO2, and PO2 of arterial blood were adjusted by changing rate and volume of the respirator and the oxygen content of inspiratory air. We also monitored arterial blood gas during the experiments and kept the values within normal limits (pH=7.45±0.01, PCO2=39±1 mm Hg, and PO2=93±4 mm Hg).
We examined responses of the basilar artery to topical application of sodium propionate (10-6 to 10-3 mol/L). Sodium propionate permeates the cells in its protonated form and releases protons, which produces intracellular acidification.18 We also examined responses to sodium nitroprusside (10-8 to 10-6 mol/L), an NO donor. Each drug was mixed in artificial CSF and suffused over the craniotomy for 5 minutes. Diameters of the basilar artery were measured immediately before and during the last minute of application of each agonist. After application of a specific drug, the vessel diameter returned to baseline level within a few minutes before application of another one. The application sequence was alternative. We also examined pH, PCO2, and PO2 of artificial CSF in the absence and presence of 1 mmol/L sodium propionate. Application of the concentration of propionate did not affect these parameters of the CSF (control: pH=7.43±0.02, PCO2=35±1 mm Hg, and PO2=119±3 mm Hg; propionate: pH=7.42±0.02, PCO2=35±1 mm Hg, and PO2=119±3 mm Hg; n=10).
We used glibenclamide (10-6 mol/L), an inhibitor of KATP channels,6 NG-nitro-L-arginine (L-NNA) (10-5 mol/L), an inhibitor of NO synthase,19 iberiotoxin (10-5 mol/L), an inhibitor of large conductance calcium-activated potassium channels,6,20 and indomethacin (10 mg/kg IV), an inhibitor of cyclooxygenase.21 Each inhibitor appears to produce maximum inhibition of its target molecule at the concentration described above.6,19–21 Glibenclamide was dissolved in dimethyl sulfoxide (DMSO). The maximum final concentration of DMSO was 0.1%. We found that 0.1% DMSO did not cause any significant changes in diameter of the basilar artery (1±2%; n=5). Other inhibitors were dissolved in distilled water. L-NNA was suffused starting from 15 minutes before and during application of propionate or nitroprusside. Suffusion of other inhibitors was started from 5 minutes before application of sodium propionate or sodium nitroprusside. Topical application of these agents did not cause any changes in systemic arterial pressure.
To confirm the importance of pHi changes in propionate-induced vasodilatation, we tested the effects of 5-N,N-hexamethyleneamiloride, an inhibitor of Na+/H+ exchanger,18,22,23 on the vasodilatation. 5-N,N-Hexamethyleneamiloride (3 µmol/L) was dissolved in DMSO and suffused 5 minutes before and during application of sodium propionate or sodium nitroprusside. The final concentration of DMSO in the CSF was 0.1%.
Reverse Transcription and Polymerase Chain Reaction
Basilar arterial muscle cells were collected from the basilar artery of male Sprague-Dawley rats (aged 4 to 6 weeks).24 After they were anesthetized with diethyl ether, the animals were decapitated, and the basilar artery was quickly removed under sterile conditions. The arterial segments were carefully cleaned of connective tissue, cut into small fragments, and placed in culture dishes coated with collagen type 1. The growth medium (Dulbecco’s modified Eagle’s medium) was supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin solution. The dishes were incubated at 37°C in a humidified atmosphere of 95% air and 5% CO2. After a few days, colonies of vascular muscle cells proliferated from the basilar arterial segments. After the arterial segment was removed, the primary vascular muscle cell colonies were gently scraped off and subcultured in other dishes. Final characterization of the cells was performed by demonstrating the absence of di-I LDL uptake and the expression of smooth muscle–specific 
-actin.
Total RNA was prepared from cultured basilar arterial muscle cells with TRIzol reagent (Life technologies, Inc).25 With the use of 1 µg total RNA, first strand cDNA synthesis was performed by AMV transcriptase in 20 µL (Roche Diagnostics). With the use of aliquots (1 µL) of reverse transcriptase (RT) products, polymerase chain reaction (PCR) reactions were performed in 50 µL final volumes with the gene-specific primers listed in Table 1. Amplification was performed for 30 cycles of denaturation at 94°C (30 seconds), annealing at 60°C (30 seconds), and extension at 72°C (60 seconds), followed by 7 minutes of extension reaction at 72°C. PCR products were separated on 1% agarose gel.
|
We also examined the expression of KATP channels in pancreatic cells. After they were anesthetized with diethyl ether, male Sprague-Dawley rats (aged 6 weeks) were decapitated, and the pancreas was quickly removed. The organ was dispersed with a dispersing generator (POLYTRON PT2100, Kinematica AG), and total RNA was prepared with TRIzol reagent. RT-PCR was performed as described above.
Statistical Analysis
All values were expressed as mean±SEM. One-way repeated-measures ANOVA was used to compare concentration-dependent responses to vasodilators. Two-way repeated-measures ANOVA was used to compare responses under control conditions and during interventions. When a significant F value was found, post hoc analysis was performed with the Wilcoxon test. A value of P<0.05 was considered significant.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Propionate-Induced Vasodilatation
Under control conditions, diameter of the basilar artery was 224±7 µm (n=20). Topical application of sodium propionate (10-6 to 10-3 mol/L) produced dilatation of the basilar artery in a concentration-related manner (Figure 1). Vasodilatation induced by propionate (10-6 to 10-3 mol/L) was reproducible since there was no significant attenuation of the response during repeated application of propionate (first: 11±2%, 19±3%, 28±5%, 36±6%, respectively; second: 10±2%, 19±4%, 29±6%, 34±5%, respectively; n=5). Glibenclamide, a selective inhibitor of KATP channels, had no effects on the baseline diameter of the basilar artery but inhibited dilatation of the basilar artery in response to propionate (Figure 1). We found that 10-6 mol/L glibenclamide inhibited vasodilatation in response to 10-3 mol/L sodium propionate by 46±11%. Sodium nitroprusside (10-8 to 10-6 mol/L) also produced dilatation of the basilar artery (Figure 2). Glibenclamide (10-6 mol/L) did not affect vasodilatation produced by sodium nitroprusside (Figure 2). We also tested the effects of L-NNA (10-5 mol/L), iberiotoxin (10-5 mol/L), and indomethacin (10 mg/kg IV) on propionate-induced dilatation of the basilar artery. None of the inhibitors affected propionate-induced vasodilatation (Table 2).
|
|
|
Because intracellular acidification activates the Na+/H+ exchanger, which causes efflux of protons to the extracellular space and thereby normalizes intracellular pH,18,26 inhibition of the Na+/H+ exchanger enhances intracellular acidification.26 Thus, we anticipated that inhibition of the exchanger would enhance propionate-induced vasodilatation. In the present study 5-N,N-hexamethyleneamiloride (3 µmol/L), an inhibitor of Na+/H+ exchanger, enhanced propionate-induced dilatation of the basilar artery (Figure 3); 3 µmol/L 5-N,N-hexamethyleneamiloride did not affect vasodilator responses to sodium nitroprusside (10-8 to 10-6 mol/L). The findings suggest that propionate-induced vasodilatation is dependent on intracellular acidification.
|
Presence of Kir6.1 and SUR2B
RT-PCR reactions yielded an expected-size 1275-bp PCR product for Kir6.1 but not an expected-size 1173-bp product for Kir6.2 (Figure 4), indicating that the vascular smooth muscle cells mainly expressed Kir6.1. Identical results were obtained with several independent vascular muscle isolates. On the other hand, pancreatic cells expressed Kir6.2 but not Kir6.1 (Figure 4). We also tested whether the vascular cells expressed SUR2B, which is reported to be present in rat coronary arterial muscle cells. RT-PCR reactions yielded an expected-size 858-bp PCR product for SUR2B (Figure 4).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
There are 2 major new findings in the present study. First, intracellular acidosis of vascular muscle by sodium propionate produced marked dilatation of the basilar artery, and the vasodilatation may be mediated, at least in part, by activation of KATP channels in vivo. Second, Kir6.1 but not Kir6.2 was expressed in the basilar arterial muscle cells. Because SUR2B was also expressed in the muscle cells, Kir6.1/SUR2B may be the major KATP channels that mediate propionate-induced dilatation of the basilar artery.
During cerebral ischemia, dilatation of the cerebral arteries appears to occur.1 The mechanisms of ischemia-induced vasodilatation are very complicated.1 Several factors, including hypoxia and hypercapnia, may account for ischemia-induced vasodilatation. Because both hypoxia and hypercapnia may be accompanied by intracellular and extracellular acidosis and acidosis itself produces marked dilatation of the cerebral arteries,2,3 decrease of pHo and pHi may play an important role in dilatation of the cerebral arteries during hypoxia and hypercapnia. In the present study we focused on intracellular acidosis because that may be the first phenomenon that occurs after ischemic insult. Sodium propionate appears to decrease pHi without affecting pHo.18 We also showed that propionate did not affect pHo, PCO2, or PO2 in the artificial CSF. Because propionate caused marked dilatation of the basilar artery, intracellular acidosis of vascular muscle itself may produce dilatation of the artery in vivo. Moreover, 5-N,N-hexamethyleneamiloride enhanced dilatation of the basilar artery in response to sodium propionate. The findings may also support the interpretation that propionate-induced dilatation of the basilar artery may be mediated by intracellular acidification in vivo.
To examine the role of KATP channels in propionate-induced dilatation of the basilar artery, we tested effects of glibenclamide, an inhibitor of KATP channels, 6 on the vasodilatation. Glibenclamide inhibited propionate-induced dilatation of the artery by approximately 50%. Thus, dilatation of the artery in response to intracellular acidosis may be mediated, in large part, by activation of KATP channels in vivo. The findings are similar to those of Ishizaka and Kuo27 that acidosis-induced relaxation of porcine coronary artery is mediated primarily by activation of KATP channels in vitro. The mechanisms of acidosis-induced activation of KATP channels are still unclear. Ishizaka and Kuo27 have suggested that acidosis produces activation of pertussis toxin–sensitive GTP-binding protein and thereby causes vasorelaxation. Recently, Xu et al,9 using a patch-clamp technique, showed that protons activate the intracellular domain of KATP channels and increase the open probability of the channels. Thus, it may be possible that selective intracellular acidification activates KATP channels of basilar arterial muscle cells and thereby causes dilatation of the artery.
We also tested the effects of 3 other inhibitors, ie, L-NNA, iberiotoxin, and indomethacin. However, none of these inhibitors affected propionate-induced dilatation of the basilar artery. Thus, NO, BKCa channels, and prostanoids may not be involved in propionate-induced dilatation of the basilar artery in vivo. Horiuchi et al28 examined responses of the cerebral arteries in response to extracellular acidification by HCl and showed that both NO and KATP channels are involved in acidosis-induced relaxation of the arteries in vitro. pHo instead of pHi appears to be the major determinant of hypercapnia-induced, NO-dependent relaxation of the cerebral arteries in vitro.3 Thus, it may be possible that application of HCl to the vascular muscle reduced pHo as well as pHi and thereby activated both NO production and KATP channels of the cerebral arterioles.
Glibenclamide at the concentration of 10-5 mol/L reduced but did not abolish propionate-induced dilatation of the basilar artery. Several mechanisms may be involved in the residual vasodilatation. It is reported that normocapnic acidosis inhibited calcium influx without affecting membrane potential of vascular muscle cells.29 Thus, acidosis may also inhibit calcium channels in the vascular muscle independent of the activity of potassium channels, and the residual vasodilatation after inhibition of KATP channels is mediated by such direct inhibitory actions of acidosis on calcium channels. The activity of inward rectifier potassium channels is reported to be modulated by acidosis.30,31 Thus, we cannot exclude the possibility that inward rectifier potassium channels may be involved in the residual dilatation of the basilar artery. We also cannot exclude the possibility that other unknown mechanisms are involved in propionate-induced dilatation of the basilar artery in vivo.
KATP channels are hetero-octamers consisting of 4 sulfonylurea receptors (SUR) interacting with 4 channel subunits (Kir channels). SUR2B appears to represent the SUR in the vascular muscle type KATP channels. We also found that SUR2B was expressed in the basilar arterial muscle cells. On the other hand, both Kir6.1 and Kir6.2 are reported to be present in vascular muscle cells. Isomoto et al15 showed that coexpression of Kir6.2 and SUR2B reconstitutes the pharmacological and electrophysiological properties of KATP channels described in smooth muscle cells. However, Yamada et al32 suggested that K+ channels composed of Kir6.1 and SUR2B closely resemble KATP channels observed in vascular muscle cells. In the present study we found that Kir6.1 is expressed in the basilar arterial muscle cells; however, significant expression of Kir6.2 was not observed in the muscle cells. Thus, Kir6.1/SUR2B may be the major KATP channels in the basilar arterial muscle cells. Xu et al9 showed that protons act directly on the Kir6 subunits and thereby increase channel activity. Thus, dilatation of the basilar artery in response to intracellular acidosis may be produced by activation of Kir6.1/SUR2B channels in the basilar arterial muscle cells by protons. However, we cannot exclude the possibility that the pattern of expression of the channels in cultured muscle cells is different from that in intact cells.
In conclusion, sodium propionate produced dilatation of the basilar artery in vivo. Propionate-induced vasodilatation may be due to intracellular acidification of the basilar arterial muscle cells and may be mediated in part by activation of KATP channels. Kir6.1/SUR2B may be the major KATP channels in the basilar arterial muscle cells.
|
Acknowledgments |
|---|
This study was supported in part by a research grant for cardiovascular diseases (11C-1) from the Ministry of Health and Welfare, Japan. A part of this study was performed in the Kyushu University Station for Collaborative Research.
Received August 7, 2002; revision received October 25, 2002; accepted December 2, 2002.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Iadecola C. Cerebral circulatory dysregulation in ischemia. In: Ginsberg MD, Bogousslavsky J, eds. Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management. Malden, Mass: Blackwell Science; 1998: 319–332.
2. Dietrich HH, Dacey RG Jr. Effects of extravascular acidification and extravascular alkalinization on constriction and depolarization in rat cerebral arterioles in vitro. J Neurosurg. 1994; 81: 437–442.[Medline] [Order article via Infotrieve]
3. Tian R, Vogel P, Lassen NA, Mulvany MJ, Andreasen F, Aalkjaer C. Role of extracellular and intracellular acidosis for hypercapnia-induced inhibition of tension of isolated rat cerebral arteries. Circ Res. 1995; 76: 269–275.
4. Aalkjaer C, Peng HL. pH and smooth muscle. Acta Physiol Scand. 1997; 161: 557–566.[CrossRef][Medline] [Order article via Infotrieve]
5. Taguchi H, Heistad DD, Kitazono T, Faraci FM. ATP-sensitive K + channels mediate dilatation of cerebral arterioles during hypoxia. Circ Res. 1994; 74: 1005–1008.
6. Kitazono T, Faraci FM, Taguchi H, Heistad DD. Role of potassium channels in cerebral blood vessels. Stroke. 1995; 26: 1713–1723.
7. Faraci FM, Breese KR, Heistad DD. Cerebral vasodilation during hypercapnia: role of glibenclamide-sensitive potassium channels and nitric oxide. Stroke. 1994; 25: 1679–1683.[Abstract]
8. Faraci FM, Brian JE Jr. Nitric oxide and the cerebral circulation. Stroke. 1994; 25: 692–703.[Abstract]
9. Xu H, Cui N, Yang Z, Wu J, Giwa LR, Abdulkadir L, Sharma P, Jiang C. Direct activation of cloned KATP channels by intracellular acidosis. J Biol Chem. 2001; 276: 12898–12902.
10. Kitazono T, Faraci FM, Heistad DD. Effect of norepinephrine on rat basilar artery in vivo. Am J Physiol. 1993; 264: H178–H182.[Medline] [Order article via Infotrieve]
11. Kitazono T, Heistad DD, Faraci FM. Role of ATP-sensitive K+ channels in CGRP-induced dilatation of basilar artery in vivo. Am J Physiol. 1993; 265: H581–H585.[Medline] [Order article via Infotrieve]
12. Aschcroft FM, Gribble FM. Correlating structure and function in ATP-sensitive K+ channels. Trends Neurosci. 1998; 21: 288–294.[CrossRef][Medline] [Order article via Infotrieve]
13. Fujita A, Kurachi Y. Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system and K+ channel openers. Pharmacol Ther. 2000; 85: 39–53.[CrossRef][Medline] [Order article via Infotrieve]
14. Davis-Taber R, Choi W, Feng JL, Hoogenboom L, McNally T, Kroeger P, Shieh CC, Simmer R, Brioni JD, Sullivan JP, Gopalakrishnan M, Scott VES. Molecular characterization of human SUR2-containing KATP channels. Gene. 2000; 256: 261–270.[CrossRef][Medline] [Order article via Infotrieve]
15. Isomoto S, Kondo C, Yamada M, Matsumoto S, Higashiguchi O, Horio Y, Matsuzawa Y, Kurachi Y. A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. J Biol Chem. 1996; 271: 24321–24324.
16. Suzuki M, Li RA, Miki T, Uemura H, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Ogura T, Seino S, Marban E, Nakaya H. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res. 2001; 88: 570–577.
17. Faraci FM, Heistad DD, Mayhan WG. Role of large arteries in regulation of blood flow to brain stem in cats. J Physiol. 1987; 387: 15–23.
18. Kitazono T, Takeshige K, Cragoe EJ Jr, Minakami S. Intracellular pH changes of cultured bovine aortic endothelial cells in response to ATP addition. Biochem Biophys Res Commun. 1988; 152: 1304–1309.[CrossRef][Medline] [Order article via Infotrieve]
19. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43: 109–142.[Medline] [Order article via Infotrieve]
20. Kitazono T, Ibayashi S, Nagao T, Fujii K, Fujishima M. Role of Ca2+-activated K+ channels in acetylcholine-induced dilatation of the basilar artery in vivo. Br J Pharamacol. 1997; 120: 102–106.[CrossRef][Medline] [Order article via Infotrieve]
21. Faraci FM, Sobey CG, Chrissobolis S, Lund DD, Heistad DD, Weintraub NL. Arachidonate dilates basilar artery by lipoxygenase-dependent mechanism and activation of K+ channels. Am J Physiol. 2001; 281: R246–R253.
22. Kleyman TR, Cragoe EJ Jr. Amiloride and its analogs as tools in the study of ion transport. J Membr Biol. 1988; 105: 1–21.[CrossRef][Medline] [Order article via Infotrieve]
23. Kitazono T, Takeshige K, Cragoe EJ Jr, Minakami S. Involvement of calcium and protein kinase C in the activation of the Na+/H+ exchanger in cultured bovine aortic endothelial cells stimulated by extracellular ATP. Biochim Biophys Acta. 1989; 1013: 152–158.[Medline] [Order article via Infotrieve]
24. Kitayama J, Kitazono T, Ibayashi S, Wakisaka M, Watanabe Y, Kamouchi M, Nagao T, Fujishima M. Role of phosphatidylinositol 3-kinase in acetylcholine-induced dilatation of rat basilar artery. Stroke. 2000; 31: 2487–2493.
25. Ago T, Nunoi H, Ito T, Sumimoto H. Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47phox: triple replacement of serine 303, 304, 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47phox, thereby activating the oxidase. J Biol Chem. 1999; 274: 33644–33653.
26. Putney LK, Denker SP, Barber DL. The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol. 2002; 42: 527–552.[CrossRef][Medline] [Order article via Infotrieve]
27. Ishizaka H, Kuo L. Acidosis-induced coronary arteriolar dilation is mediated by ATP-sensitive potassium channels in vascular smooth muscle. Circ Res. 1996; 78: 50–57.
28. Horiuchi T, Dietrich HH, Hongo K, Goto T, Dacey RG Jr. Role of endothelial nitric oxide and smooth muscle potassium channels in cerebral arteriolar dilation in response to acidosis. Stroke. 2002; 33: 844–849.
29. Peng H-L, Jensen PE, Nilsson H, Aalkjaer C. Effect of acidosis on tension and [Ca2+]i in rat cerebral arteries: is there a role for membrane potential? Am J Physiol. 1998; 274: H655–H662.[Medline] [Order article via Infotrieve]
30. Ito H, Vereecke J, Carmeliet E. Intracellular protons inhibit inward rectifier K+ channels of guinea-pig ventricular cell membrane. Pflugers Arch. 1992; 422: 280–286.[CrossRef][Medline] [Order article via Infotrieve]
31. Xu H, Cui N, Yang Z, Qu Z, Jiang C. Modulation of Kir4.1 and Kir5.1 by hypercapnia and intracellular acidosis. J Physiol. 2000; 524: 725–735.
32. Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T, Seino S, Inagaki N. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science. 2001; 292: 1543–1546.
This article has been cited by other articles:
 |
|
 |
|
  J. L. Gomez, K. J. Gunnerson, M. Song, J. Li, and J. A. Kellum Effects of Hypercapnia on BP in Hypoalbuminemic and Nagase Analbuminemic Rats Chest, May 1, 2007; 131(5): 1295 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Kluess, J. B. Buckwalter, J. J. Hamann, and P. S. Clifford Acidosis attenuates P2X purinergic vasoconstriction in skeletal muscle arteries Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H129 - H132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. I. Rosenblum ATP-Sensitive Potassium Channels in the Cerebral Circulation Stroke, June 1, 2003; 34(6): 1547 - 1552. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||